UCB is a global biopharma focused on severe diseases in two therapeutic areas: central nervous system and immunology operations.
The company is listed on the Euronext Brussels Stock Exchange and has its headquarters in Brussels, Belgium. It employs more than 8,500 people in more than 40 countries.
Financial Data
-
31st Dec 17 Source: CRO
- €163 million turnover
-
€12.2 million
profit - 1 employees
-
31st Dec 16 Source: CRO
- €167.1 million turnover
-
-€10.4 million
profit - 44 employees
- 9 more years available »
Ranking
By Turnover
(€163 million)- 347th in Top Companies
- 40th in Health
- 40th in Pharma
By Employees
(1)- 990th in Top Companies
- 98th in Health
- 88th in Pharma
-
- 1
- €163 million
Employees
- Steve Turley CEO/Managing Director
Latest News
- 6:07pm Kingfisher quits Russia, Spain and Portugal as French sales tumble
- 6:01pm Nissan seeks more sway in Renault alliance as governments urge stability
- 5:27pm Sweden’s push to get rid of cash has some saying, ‘not so fast’
- 4:45pm Grant Thornton in spotlight over Patisserie Valerie
- 4:12pm Bet365 chief was paid £220m last year